Allergan | AbbVie | off-label or unapproved promotion of medical products | 2022 | WV-AG | $78,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2021 | USAO | $75,000,000 |
Bristol Myers Squibb Co. | Bristol-Myers Squibb | False Claims Act and related | 2021 | MULTI-AG | $75,000,000 |
GlaxoSmithKline | GSK plc | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $75,000,000 |
Organon Inc. | Organon & Co. | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $75,000,000 |
Boehringer Ingelheim Pharma GmbH | Boehringer Ingelheim | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $73,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $73,000,000 |
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation | Novartis | off-label or unapproved promotion of medical products | 2010 | FDA | $72,500,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $72,500,000 |
Teva Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2023 | KY-AG | $71,477,474 |
Amgen Inc. | Amgen | off-label or unapproved promotion of medical products | 2015 | MULTI-AG | $71,000,000 |
Actavis Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $71,000,000 |
Teva | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2024 | MD-AG | $70,281,867 |
GlaxoSmithKline | GSK plc | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $70,000,000 |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | MULTI-AG | $70,000,000 |
GlaxoSmithKline PLC | GSK plc | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $70,000,000 |
Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2019 | CA-AG | $69,000,000 |
AstraZeneca Pharmaceuticals | AstraZeneca | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | $68,500,000 |
Taro Pharmaceutical USA Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $67,643,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | DOJ_CIVIL | $67,000,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $65,700,000 |
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. | Endo International | off-label or unapproved promotion of medical products | 2022 | FL-AG | $65,000,000 |
Endo Health Solutions and Endo Pharmaceuticals | Endo International | off-label or unapproved promotion of medical products | 2022 | FL-AG | $65,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $65,000,000 |
GlaxoSmithKline PLC | GSK plc | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $65,000,000 |
Mylan Inc. | Viatris | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $65,000,000 |
CSL Limited | CSL Limited | price-fixing or anti-competitive practices | 2014 | private lawsuit-federal | $64,000,000 |
GlaxoSmithKline | GSK plc | drug or medical equipment safety violation | 2006 | private lawsuit-state | $63,833,148 |
Lupin Pharmaceuticals, Inc. | Lupin Limited | False Claims Act and related | 2019 | TX-AG | $63,000,000 |
Allergan PLC | AbbVie | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $62,500,000 |
Eli Lilly and Company | Eli Lilly | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | $62,000,000 |
Sanofi Pasteur Inc. | Sanofi | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $61,500,000 |
Merck & Co. | Merck | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $60,200,000 |
Forest Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $60,000,000 |
Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $60,000,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | $60,000,000 |
Endo Pharmaceuticals Inc. | Endo International | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $60,000,000 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2017 | DOJ_CIVIL | $58,650,000 |
Merck & Co. | Merck | consumer protection violation | 2008 | MULTI-AG | $58,000,000 |
Jazz Pharmaceuticals plc | Jazz Pharmaceuticals | False Claims Act and related | 2019 | DOJ_CIVIL | $57,000,000 |
Mylan Inc. | Viatris | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $57,000,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | off-label or unapproved promotion of medical products | 2014 | FDA | $56,500,000 |
Merck | Merck | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $56,000,000 |
Pfizer Inc. | Pfizer | drug or medical equipment safety violation | 2012 | FDA | $55,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $55,000,000 |
Andrx Corporation | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $55,000,000 |
Hoechst Marion Roussel | Sanofi | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $55,000,000 |
Johnson & Johnson Vision Care Inc. | Johnson & Johnson | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $55,000,000 |
Schering-Plough Corporation | Merck | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $55,000,000 |
GlaxoSmithKline LLC | GSK plc | False Claims Act and related | 2019 | IL-AG | $54,653,931 |
Salix Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2016 | USAO | $54,000,000 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2019 | private lawsuit-federal | $54,000,000 |
Lundbeck LLC | Lundbeck | False Claims Act and related | 2019 | DOJ_CIVIL | $52,600,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $52,000,000 |
Allergan Inc. | AbbVie | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $51,250,000 |
Endo Health Solutions | Endo International | off-label or unapproved promotion of medical products | 2021 | NY-AG | $50,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $50,000,000 |
E. Merck KG | Merck KGaA (EMD) | price-fixing or anti-competitive practices | 2002 | private lawsuit-federal | $50,000,000 |
Hoechst Marion Roussel, Inc. | Sanofi | price-fixing or anti-competitive practices | 2016 | private lawsuit-state | $50,000,000 |
Watson Laboratories | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2016 | private lawsuit-state | $50,000,000 |
Pfizer Inc. | Pfizer | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $50,000,000 |
Johnson & Johnson | Johnson & Johnson | False Claims Act and related | 2019 | IL-AG | $49,505,368 |
Merck & Co., Inc. | Merck | benefit plan administrator violation | 2011 | private lawsuit-federal | $49,500,000 |
Pfizer Corporation | Pfizer | False Claims Act and related | 2002 | DOJ_CIVIL | $49,000,000 |
Apotex Corporation | Apotex Corp. | False Claims Act and related | 2021 | DOJ_CIVIL | $49,000,000 |
GlaxoSmithKline PLC | GSK plc | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $49,000,000 |
Allergan PLC | AbbVie | off-label or unapproved promotion of medical products | 2023 | KY-AG | $48,666,145 |
Johnson & Johnson | Johnson & Johnson | Foreign Corrupt Practices Act | 2011 | SEC | $48,600,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $48,000,000 |
Hoffman-LaRoche | Roche | price-fixing or anti-competitive practices | 2000 | CA-AG | $47,498,000 |
SmithKline Beecham | GSK plc | False Claims Act and related | 2003 | DOJ_CIVIL | $47,000,000 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | DOJ_CIVIL | $46,500,000 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $46,500,000 |
Par Pharmaceutical Companies Inc. | Endo International | off-label or unapproved promotion of medical products | 2013 | FDA | $45,000,000 |
Bausch Health | Bausch Health | accounting fraud or deficiencies | 2020 | SEC | $45,000,000 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2002 | private lawsuit-federal | $45,000,000 |
DuPont Pharmaceuticals Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2002 | private lawsuit-federal | $44,500,000 |
Serono Laboratories Inc. | Merck KGaA (EMD) | False Claims Act and related | 2011 | DOJ_CIVIL | $44,300,000 |
EMD Serono, Inc. | Merck KGaA (EMD) | False Claims Act and related | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $44,300,000 |
Elan Corp. | Perrigo | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $43,399,040 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | $42,900,000 |
Alpharma Inc. | Pfizer | False Claims Act and related | 2010 | DOJ_CIVIL | $42,500,000 |
Kos Pharmaceuticals | AbbVie | kickbacks and bribery | 2010 | FDA | $41,500,000 |
Merck | Merck | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $41,500,000 |
Briston-Myers Squibb | Bristol-Myers Squibb | benefit plan administrator violation | 2005 | private lawsuit-federal | $41,220,000 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2019 | IL-AG | $41,047,101 |
Actavis Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $41,000,000 |
GlaxoSmithKline, LLC | GSK plc | drug or medical equipment safety violation | 2011 | MULTI-AG | $40,750,000 |
Janssen Pharmaceuticals/Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2022 | NH-AG | $40,500,000 |
Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2022 | NH-AG | $40,500,000 |
Andrx Corporation | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $40,000,000 |
Aventis Pharmaceutical Inc. | Sanofi | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $40,000,000 |
GlaxoSmithKline | GSK plc | False Claims Act and related | 2003 | MULTI-AG | $40,000,000 |
GlaxoSmithKline | GSK plc | drug or medical equipment safety violation | 2008 | private lawsuit-federal | $40,000,000 |
Endo Pharmaceuticals Inc. | Endo International | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $40,000,000 |
Apotex | Apotex Corp. | price-fixing or anti-competitive practices | 2024 | MULTI-AG | $39,100,000 |
Daiichi Sankyo Inc. | Daiichi Sankyo | False Claims Act and related | 2015 | DOJ_CIVIL | $39,000,000 |
Endo Pharmaceuticals Inc. and Vintage Pharmaceuticals, LLC d/b/a Qualitest Pharmaceuticals | Endo International | drug or medical equipment safety violation | 2015 | USAO | $39,000,000 |
Daiichi Sankyo, Inc. | Daiichi Sankyo | False Claims Act and related | 2015 | MULTI-AG | $39,000,000 |
Endo Health Solutions | Endo International | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $39,000,000 |